Posted on Thursday January 01, 1970
Adjuvant Anti-CDK Thwarts Early Breast Cancer RecurrencePosted on Sunday September 20, 2020
(MedPage Today) -- Including a CDK4/6 inhibitor in adjuvant therapy significantly increased invasive disease-free survival (iDFS) in patients with high-risk early, hormone receptor (HR)-positive breast cancer, a large randomized trial showed....
Newly Approved Drug Boosts Survival in Metastatic TNBCPosted on Sunday September 20, 2020
(MedPage Today) -- Triple-negative breast cancer (TNBC) patients saw a significant survival benefit when treated with third-line sacituzumab govitecan (Trodelvy) rather than chemotherapy, phase III findings from the ASCENT trial showed. The trial...
How To Talk About Suicide; Employer Plans Leave Many UnderinsuredPosted on Sunday September 20, 2020
(MedPage Today) -- Welcome to this week's edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the Web to help you learn what's next.Struggling to find the right words when...
Neoadjuvant IO Yields Deep Responses in Head and Neck CancerPosted on Sunday September 20, 2020
(MedPage Today) -- Preoperative checkpoint inhibition led to deep responses in select patients with head and neck squamous cell carcinoma (SCC) with mostly human papillomavirus (HPV)-negative disease, a small, single-arm study found. Among 29...
COVID and AIDS: The Past Is PresentPosted on Sunday September 20, 2020
(MedPage Today) -- As our nation faces one of the greatest public health and economic challenges of the century, many of us are reminded of similar events in our country's history. Before COVID-19, another condition emerged that changed the way...
